Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast

OSUWexnerbloglogo2014 Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast. Here in the United States, the incidence of hepatocellular carcinoma is rising. The way that we approach cancer of the liver has changed over the past 20 years and today on MedNet, we are going to bring you up to date on the epidemiology, screening, diagnosis, and treatment of hepatocellular carcinoma. Joining us today is hepatologist and Assistant Professor of Internal Medicine, Dr. Lanla F. Conteh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the epidemiology of hepatocellular carcinoma in the United States; and RECOGNIZE which patients should be screened for hepatocellular carcinoma.

You’ll also learn about the following:

  • The rising incidence of hepatocellular carcinoma
  • New directions in treatment of hepatocellular carcinoma
  • Imaging test of choice in suspected hepatocellular carcinoma
  • How to biopsy suspected hepatocellular carcinoma
  • Viral hepatitis risk factors for hepatocellular carcinoma
  • Fibrolamellar hepatocellular carcinoma

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Understanding the Management of Depression

OSUWexnerbloglogo2014 Understanding the Management of Depression. We now have more and better medications to treat depression than the anti-tuberculosis drug created in the 1950’s. We also have much better ways to screen and identify patients with depression. We’re pleased to welcome our guests today to tell us about depression in primary care. Dr. Nazhat Taj-Schaal is an Assistant Professor of Internal Medicine in the Division of General Internal Medicine and Kelli Barnes is a pharmacist and Assistant Professor in the College of Pharmacy.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW recent updated clinical guidelines that address screening for depression, monitoring treatment effects, and integration of behavioral health into primary care; and REVIEW medication treatment options, their unique characteristics and how to choose between different therapies.

You’ll also learn about the following:

  • Epidemiology of depression
  • Different antidepressants have different properties
  • Managing depressed patients in a busy primary care practice
  • Identifying the suicidal patient
  • Practical approach to antidepressant selection
  • Setting realistic expectations for antidepressant effects

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Provides a Thyroid Update

OSUWexnerbloglogo2014 CME Webcast Provides a Thyroid Update. Overall, 20 million Americans have some form of thyroid disease and over their lifetimes, 1 out of every 8 women will develop a thyroid disease. On this CME webcast, we’re going to hear about the spectrum of thyroid disorders. Joining our moderator in the studio is endocrinologist and Assistant Professor of Internal Medicine, Dr. Elizabeth Buschur.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the diagnosis and management of hypo- and hyperthyroidism; DIAGNOSE and manage a thyroid nodule.

You’ll also learn about the following:

  • Risk factors for thyroid disease
  • Epidemiology of thyroid disease
  • Thyroid storm
  • Myxedema coma
  • Choosing a thyroid replacement product
  • Over-the-counter animal thyroid replacement
  • Thyroid drug interactions
  • T3 levels, thyroglobulin antibodies, and thyroid peroxidase antibodies
  • Approach to the incidental goiter

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn about Heart Disease in Women

OSUWexnerbloglogo2014 Learn about Heart Disease in Women on our latest webcast. Heart disease is different between men and women, the symptoms can be different and even the types of heart diseases can be different.  Joining our moderator, Dr. Jim Allen, in the studio to update us on heart disease in women is Associate Professor of Internal Medicine and the Director of the Women’s Cardiovascular Health Program at the Ohio State University, Dr. Laxmi Mehta.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the risk factors and clinical presentation of cardiovascular disease in women; and REVIEW causes of myocardial infarction in women without obstructive coronary artery disease.

You’ll also learn about the following:

  • Gender differences in cardiovascular disease symptoms and outcomes
  • Gender differences in heart disease epidemiology
  • Gender differences in cardiovascular stress tests
  • Statins and aspirin in women
  • Birth control pills and cardiovascular disease

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Thyroid Cancer During CME Webcast

OSUWexnerbloglogo2014 Learn About Thyroid Cancer During CME Webcast. On this CME webcast, we’re going to talk about thyroid nodules: which ones need to be biopsied and which ones can be followed. And then we’re going to talk about thyroid cancer: how to diagnose it, how to treat it, and how to follow it. Our guest today is an endocrinologist and Associate Professor of Internal Medicine at the Ohio State University, Dr. Jennifer Sipos.  Enjoy this introduction.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the epidemiology of thyroid nodules and thyroid cancer; and OUTLINE the general management principles for thyroid cancer.

You’ll also learn about the following:

  • Physical examination of the thyroid gland
  • Detection of thyroid nodules by exam
  • Thyroid cancer histology and prognosis
  • Side effects of thyroid cancer surgery
  • Management of metastatic thyroid cancer
  • Role of CT scans in thyroid nodule detection and evaluation
  • Long-term follow-up of simple cysts of the thyroid
  • Evaluation of the multinodular goiter

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.